Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL trial of partial oral antibiotic treatment for bacterial brain abscess
NL-OMON60107Phase 4Recruiting
- Sponsor
- Aalborg University Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metronidazole in brain abscess (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Primary composite endpoint at 6 months. Started May 2023; status: recruiting.
02
Drugs
metronidazole
03
Conditions
brain abscess
Beyond the preview
Go deeper on NL-OMON60107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60107.